Report cover image

Veterinary/Animal Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published May 01, 2025
Length 167 Pages
SKU # FOB20106860

Description

Growth Factors of Veterinary/Animal Vaccines Market

The global veterinary/animal vaccines market is witnessing strong and consistent growth driven by increasing concerns over animal health, the rising prevalence of zoonotic diseases, and growing livestock populations worldwide. According to Fortune Business Insights, the global animal vaccines market was valued at USD 13.47 billion in 2023 and is projected to grow from USD 14.43 billion in 2024 to USD 24.85 billion by 2032, demonstrating a rising demand for effective immunization in both companion and livestock animals.

Rising Zoonotic Threats and Livestock Industry Expansion

The continued risk of zoonotic diseases, such as rabies, avian influenza, and swine flu, has placed a renewed focus on preventive healthcare for animals. These diseases not only affect animal welfare but also pose a severe risk to human health, especially in regions where people live in close proximity to animals. Governments and international health organizations are increasingly prioritizing mass vaccination campaigns, especially in developing economies, to curb the transmission of such infections.

Meanwhile, livestock farming is expanding across Asia and Latin America to meet the growing global demand for protein-rich foods. This surge has driven the need for livestock vaccination programs, particularly for diseases like foot-and-mouth disease (FMD), bovine viral diarrhea (BVD), and brucellosis, which significantly impact productivity and export potential.

Companion Animal Vaccination Trends

Alongside livestock, companion animal vaccination is gaining momentum, particularly in developed economies. Rising pet ownership, increasing awareness of animal health, and a growing inclination to spend on pet care have all contributed to rising demand for vaccines against common ailments such as rabies, distemper, parvovirus, and feline leukemia.

The pet insurance industry and veterinary clinics have also fueled the uptake of vaccination as a preventive healthcare measure, ensuring long-term well-being of household pets.

Technological Innovations and Vaccine Advancements

The veterinary vaccine market is witnessing a technological transformation with the introduction of DNA-based vaccines, vector vaccines, and live attenuated vaccines. These advancements are improving vaccine stability, efficacy, and ease of administration.

Companies are also investing in thermostable vaccines that can be distributed in remote areas with limited cold-chain infrastructure, expanding access in rural regions of Asia and Africa.

Moreover, needle-free delivery systems, intradermal vaccines, and oral formulations are simplifying administration and improving compliance, particularly in poultry and swine sectors.

Regional Insights

North America dominates the global animal vaccines market, driven by advanced veterinary infrastructure, high pet adoption rates, and established livestock industries in the U.S. and Canada.

Europe follows closely, with increasing focus on preventing disease outbreaks among both domestic and wild animals. Countries such as Germany, the U.K., and France invest heavily in animal healthcare and zoonosis prevention.

Asia Pacific is the fastest-growing region, fueled by large-scale livestock production, government immunization programs, and rising awareness of animal health in countries like India, China, and Indonesia.

Latin America and the Middle East & Africa also present growth opportunities, particularly due to expanding livestock farming and emerging veterinary health infrastructure.

Key Players and Competitive Landscape

Prominent companies in the veterinary vaccines market include:

Zoetis Inc.

Merck Animal Health

Elanco Animal Health

Boehringer Ingelheim Animal Health

Ceva Santé Animale

Phibro Animal Health

Hester Biosciences

Indian Immunologicals Ltd.

Virbac

Bayer Animal Health

These companies are focusing on product innovation, mergers and acquisitions, and geographic expansion to strengthen their market presence. Collaborations with research institutions and government bodies are also key strategies to develop and distribute vaccines in underserved regions.

Strategic Outlook

The veterinary/animal vaccines market is poised for robust growth through 2032, supported by strong global demand for food security, pet care, and disease prevention. As public health concerns intersect with animal health, vaccines will continue to play a pivotal role in sustainable livestock management and companion animal care. Strategic investments in R&D, cold-chain logistics, and regulatory partnerships will shape the future of this dynamic market.

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2024

Estimated Year 2025

Forecast Period 2025-2032

Historical Period 2019-2023

Growth Rate CAGR of 5.8% from 2025 to 2032

Unit Value (USD Billion)

Segmentation By Product

Inactivated

Live Attenuated

Recombinant

Others

By Animal

Companion

Feline

Canine

Avian

Others

Livestock

Poultry

Porcine

Bovine

Others

By Route of Administration

Oral

Parenteral

Others

By Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Pharmacies & Drug Stores

Others

By Region

North America (By Product, Animal, Route of Administration, Distribution Channel, and Country/ Sub-Region)

U.S.

Canada

Europe (By Product, Animal, Route of Administration, Distribution Channel, and Country/ Sub-Region)

U.K.

Germany

France

Italy

Spain

Scandinavia

Rest of Europe

Asia Pacific (By Product, Animal, Route of Administration, Distribution Channel, and Country/ Sub-Region)

Japan

China

India

Australia

Southeast Asia

Rest of Asia Pacific

Latin America (By Product, Animal, Route of Administration, Distribution Channel, and Country/ Sub-Region)

Brazil

Mexico

Rest of Latin America

Middle East & Africa (By Product, Animal, Route of Administration, Distribution Channel, and Country/ Sub-Region)

GCC

South Africa

Rest of the Middle East & Africa

Please Note:

It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

167 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2024
4.2. Regulatory Scenario By Key Countries/ Region, 2024
4.3. Pet Ownership Statistics, By Key Countries/ Region, 2024
4.4. Overview of Vaccination for Different Animal Diseases
4.5. New Product Launches, By Key Players
4.6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4.7. Impact of COVID-19 on the Global Veterinary Vaccines Market
5. Global Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product
5.1.1. Inactivated
5.1.2. Live Attenuated
5.1.3. Recombinant
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Animal Type
5.2.1. Companion
5.2.1.1. Feline
5.2.1.2. Canine
5.2.1.3. Avian
5.2.1.4. Others
5.2.2. Livestock
5.2.2.1. Poultry
5.2.2.2. Porcine
5.2.2.3. Bovine
5.2.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Route of Administration
5.3.1. Oral
5.3.2. Parenteral
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Veterinary Hospitals
5.4.2. Veterinary Clinics
5.4.3. Pharmacies & Drug Stores
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product
6.1.1. Inactivated
6.1.2. Live Attenuated
6.1.3. Recombinant
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Animal Type
6.2.1. Companion
6.2.1.1. Feline
6.2.1.2. Canine
6.2.1.3. Avian
6.2.1.4. Others
6.2.2. Livestock
6.2.2.1. Poultry
6.2.2.2. Porcine
6.2.2.3. Bovine
6.2.2.4. Others
6.3. Market Analysis, Insights and Forecast – By Route of Administration
6.3.1. Oral
6.3.2. Parenteral
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Distribution Channel
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
6.4.3. Pharmacies & Drug Stores
6.4.4. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product
7.1.1. Inactivated
7.1.2. Live Attenuated
7.1.3. Recombinant
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Animal Type
7.2.1. Companion
7.2.1.1. Feline
7.2.1.2. Canine
7.2.1.3. Avian
7.2.1.4. Others
7.2.2. Livestock
7.2.2.1. Poultry
7.2.2.2. Porcine
7.2.2.3. Bovine
7.2.2.4. Others
7.3. Market Analysis, Insights and Forecast – By Route of Administration
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Distribution Channel
7.4.1. Veterinary Hospitals
7.4.2. Veterinary Clinics
7.4.3. Pharmacies & Drug Stores
7.4.4. Others
7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.5.1. Germany
7.5.2. U.K.
7.5.3. France
7.5.4. Italy
7.5.5. Spain
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product
8.1.1. Inactivated
8.1.2. Live Attenuated
8.1.3. Recombinant
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Animal Type
8.2.1. Companion
8.2.1.1. Feline
8.2.1.2. Canine
8.2.1.3. Avian
8.2.1.4. Others
8.2.2. Livestock
8.2.2.1. Poultry
8.2.2.2. Porcine
8.2.2.3. Bovine
8.2.2.4. Others
8.3. Market Analysis, Insights and Forecast – By Route of Administration
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Distribution Channel
8.4.1. Veterinary Hospitals
8.4.2. Veterinary Clinics
8.4.3. Pharmacies & Drug Stores
8.4.4. Others
8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product
9.1.1. Inactivated
9.1.2. Live Attenuated
9.1.3. Recombinant
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Animal Type
9.2.1. Companion
9.2.1.1. Feline
9.2.1.2. Canine
9.2.1.3. Avian
9.2.1.4. Others
9.2.2. Livestock
9.2.2.1. Poultry
9.2.2.2. Porcine
9.2.2.3. Bovine
9.2.2.4. Others
9.3. Market Analysis, Insights and Forecast – By Route of Administration
9.3.1. Oral
9.3.2. Parenteral
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Distribution Channel
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.4.3. Pharmacies & Drug Stores
9.4.4. Others
9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Veterinary Vaccines Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product
10.1.1. Inactivated
10.1.2. Live Attenuated
10.1.3. Recombinant
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Animal Type
10.2.1. Companion
10.2.1.1. Feline
10.2.1.2. Canine
10.2.1.3. Avian
10.2.1.4. Others
10.2.2. Livestock
10.2.2.1. Poultry
10.2.2.2. Porcine
10.2.2.3. Bovine
10.2.2.4. Others
10.3. Market Analysis, Insights and Forecast – By Route of Administration
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Distribution Channel
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Pharmacies & Drug Stores
10.4.4. Others
10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2024)
11.2. Company Profiles
11.2.1. Elanco
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. HIPRA
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Boehringer Ingelheim International GmbH
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Virbac
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Merck Animal Health
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Zoetis Services LLC
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Ceva
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. NEOGEN CORPORATION
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Hester Biosciences Limited
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us